The transgene was designed to have the mouse prion protein promoter sequences (from vector MoPrp.Xho) and a human wild-type Fused in sarcoma (FUS) cDNA sequence with N-terminal hemagglutinin-tag (HA-hFUS). Three founders were established, including line WT3.